JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
ESLAW - Estrella Immunopharma, Inc.
USD | NASDAQ | Healthcare
Summary
Summary ESLAW Stock
Financials
Financials ESLAW Stock
Loading...
Loading...
Income Statement
Income Statement ESLAW Stock
Balance Sheet
Balance Sheet ESLAW Stock
Cash Flow Statement
Cash Flow Statement ESLAW Stock
Loading...
Loading...
Home
Stocks
Estrella Immunopharma, Inc. (ESLAW)
Financials
Financials of ESLAW
Loading...
Loading...
ESLAW Financials - Estrella Immunopharma Income & Cash Flow | Ledgeburg
Loading...
Loading...
Revenue
N/A
Operating Income
$-13.062674M
Net Income
$-13.063512M
Share Count (Basic)
36.82081M
Operating Cash Flow
$-1.785679M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$1.384302M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
No data available
Revenue $USD
No data available
Annual
Quarterly
Net Income $USD
-10M
-5M
0
FY2021
Annual
Quarterly
Margins
No data available
Margins
No data available
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-6M
-5M
-4M
-3M
-2M
-1M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26